Sensitivity controls for blood serology prepared from modified cells
AssigneeKIWI Ingenuity Limited
InventorsDeborah Adella Blake, Lissa Gwyneth Gilliver, Stephen Michael Henry, Ji Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeKIWI Ingenuity Limited
InventorsDeborah Adella Blake, Lissa Gwyneth Gilliver, Stephen Michael Henry, Ji Chen
Estimating the term…
The invention provides for a process for preparing a sensitivity control for blood group determination including dissolving an amount of an antigen in water to give an antigen solution of known concentration, contacting the antigen solution with cells to allow insertion of antigen molecules into the cell membranes of the cells to give transformed cells or contacting the antigen solution with cells that have been modified by the insertion of a linker molecule into the membranes of the cells to allow attachment of antigen molecules to the linker molecules to give transformed cells, washing the transformed cells to give a transformed cell solution, and determining the concentration of the transformed cell solution to enable the solution to be used as a sensitivity control for blood group determination.
A sensitivity control composition comprising a suspension of modified red blood cells for use in blood group determination where the modified red blood cells are modified by insertion of group A or group B blood group antigen glycolipids, or a mixture thereof, in known concentrations into the membranes of group O red blood cells.
Dependencies are inferred from the claim text.